Reinacher-Schick, Anke

Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer

New England Journal of Medicine | March 25, 2026 | Volume: 394 | Issue: 12 | Pages: 1155-1166

10.1056/nejmoa2507874 | PMID 41880612